FindTrial
Sign In

Multicentric study on outcome of treatment of osteosarcoma in India, conducted by Indian Musculo Skeletal Oncology Society

Evaluation of clinico-pathological characteristics, prognostic factors and treatment outcomes in patients with osteosarcoma in children and adults treated in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053100
Enrollment
1000
Registered
2023-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C40-C41- Malignant neoplasms of bone and articular cartilage

Interventions

None listed

Sponsors

Indian Musculo Skeletal Oncology Society (IMSOS)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with proven tissue diagnosis of osteosarcoma diagnosed on January 2001 or later, and treated in India for the same

Exclusion criteria

Exclusion criteria: Patients without histopathologically confirmed diagnosis of osteosarcoma

Design outcomes

Primary

MeasureTime frame
Overall and event free survival will be assessed as primary outcome over the time period of five years.Timepoint: Five years—

Secondary

MeasureTime frame
Relationship of prognostic variables with overall and event free survival will be assessed as secondary outcome over the period of five years.Timepoint: Five years—

Countries

India

Contacts

Public ContactAkshay Tiwari

National Accreditation Board for Hospitals & Healthcare Providers, Joint Commission International

akshay_t_2000@yaho.com9818002611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026